-
Democrat in key US Senate race denies sex assault claim
-
US leads international concern after China test-fires missile into Pacific
-
Samsung expects 1,800% leap in quarterly operating profit on AI boom
-
Close to tears and on his own as Ronaldo's World Cup dream ends
-
Russian strikes kill at least 26 in Kyiv region on eve of NATO summit
-
Argentina's gruelling World Cup schedule a concern for Scaloni
-
Ronaldo 'won't make rash decisions' following last World Cup game
-
Race to recover bodies ahead of Venezuela quake cleanup
-
Paraguay govt slams lawmaker for racially abusing France's Mbappe
-
Egypt coach Hassan says Palestinian suffering 'a shame on the world'
-
US embraces Balogun World Cup reprieve as world seethes
-
NBA Kings waive six-time All-Star forward DeRozan
-
Spain win it late to give Ronaldo bitter end to World Cup career
-
Greaves and Hope centuries usher West Indies towards safety
-
Spain edge Portugal to end Ronaldo World Cup dream, US eye quarters
-
'I celebrated in bed' -- Norway's Solbakken stays grounded after beating Brazil
-
Spain win it late to bid farewell to Ronaldo at World Cup
-
Canada chooses Germany's TKMS to build new fleet of submarines
-
Trump's fireworks made Washington world's most polluted city
-
Mbappe condemns racist abuse by Paraguayan senator after World Cup clash
-
Stock markets meander as US tech stocks climb
-
FIFA chief forced to defend Balogun World Cup reprieve
-
Britain's Fery stuns Dimitrov, Paolini into Wimbledon quarters
-
Antetokounmpo says goodbye to Milwaukee in video
-
Russian strikes kill 24 in Kyiv region on eve of NATO summit
-
Fairytale Fery sinks Dimitrov to make Grand Slam history at Wimbledon
-
Trump touts latest White House renovation: a new helipad
-
Canadian Artemis II crew member to retire from space agency
-
Fritz powers past Bublik, into Wimbledon last eight again
-
Prince Harry arrives in UK amid security spat
-
Ovechkin won't say next NHL season will be his last
-
'Agony' in Cuba amid third nationwide blackout in six months
-
Djokovic, Sinner aim to book Wimbledon blockbuster
-
For Trump's World Cup, 'America First' collides with world's game
-
Record fireworks display choked Washington in toxic smoke
-
England's World Cup campaign takes flight with Mexico win
-
Macron in Syria on first post-Assad visit by West European head of state
-
Tour de France stage record still 'far away' for Pogacar
-
US streamers launch new legal fight against French content rules
-
Infantino told Trump FIFA disciplinary body is 'independent'
-
EU tells France to amend social media ban law
-
Japanese forward Hachimura signs with Clippers: reports
-
Losses from latest French museum heist estimated at 4.5 mln euros
-
After designing Taylor Swift's wedding dress, Dior's Anderson returns to catwalk
-
Big defence spending, aid cuts: German cabinet approves budget
-
Russian strikes kill 22 in Kyiv region on eve of NATO summit
-
Microsoft cuts 4,800 jobs as it revamps Xbox
-
Pogacar back in 'special' yellow after Tour de France stage three victory
-
Don't let AI shape humanity's future: UN chief
-
Paolini ends Eala run ahead of Wimbledon wildcard clash
Bionoid Pharma, Inc. Reports Over $100,000 in Revenue Following Binding LOI With Your Supplement Supply Store Ltd.
Bionoid Pharma, Inc. ("Bionoid") (OTC PINK:BINP) is pleased to announce the generation of over $100,000 in revenue following the signing of a Binding Letter of Intent (LOI) with Your Supplement Supply Store Ltd. This significant milestone underscores the strategic value of the agreement and demonstrates the potential of Bionoid's growth strategy.
The LOI with Your Supplement Supply Store Ltd. represents a pivotal step in Bionoid's expansion into the health and wellness e-commerce sector. Under the terms of the agreement, Bionoid retains all revenue generated during the transition period prior to the finalization of the Asset Purchase Agreement (APA). This structure has enabled Bionoid to capture immediate value while ensuring a seamless integration process.
"The revenue generated from this agreement is a testament to the strength of our strategic partnerships and our ability to drive results even before completing the acquisition process," said Wayne Cockburn, CEO of Bionoid Pharma, Inc. "This success reinforces our commitment to building a robust e-commerce presence in the health and wellness sector and highlights the potential for future growth as we continue to execute our long-term vision."
Bionoid's strategy focuses on acquiring high-value e-commerce platforms and leveraging its proprietary AI Maverick technology to optimize customer engagement and operational efficiency. The success of this initial revenue generation further positions the company as a leader in the health and wellness market.
About Bionoid Pharma, Inc.
Bionoid Pharma, Inc. is a forward-thinking health and wellness company dedicated to expanding revenue streams and enhancing brand presence through strategic acquisitions and advanced AI technology. Its proprietary AI Maverick platform supports the company's mission to deliver innovative, AI-driven solutions that foster customer loyalty, operational excellence, and sustainable growth.
Stay connected:
Website: BionoidPhama.com
OTC Markets: BINP
X (formally Twitter)
For further information, contact:
Wayne Cockburn, CEO
Phone: (905) 505-0770
Email: [email protected]
SOURCE: Bionoid Pharma, Inc.
O.Brown--AT